From research to market – Your reliable partner
Every oligonucleotide is unique.
Therefore, BioSpring develops individual analytical solutions for each oligonucleotide. Within the last twenty years, our experienced team has developed and tuned hundreds of sequence- and structure-specific high-resolution methods.
For clinical applications we validate these methods according to ICH guidelines. Throughout the whole drug-development cycle, we support our customers with our analytical experience and expertise: